Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Accelerate Diagnostics, Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company, dedicated in providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
IPO Date: May 1, 1994
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $3.74M
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.35 | 3.32%
Avg Daily Range (30 D): $0.03 | 9.21%
Avg Daily Range (90 D): $0.04 | 5.45%
Institutional Daily Volume
Avg Daily Volume: .26M
Avg Daily Volume (30 D): 2.98M
Avg Daily Volume (90 D): 1.03M
Trade Size
Avg Trade Size (Sh.): 159
Avg Trade Size (Sh.) (30 D): 1,578
Avg Trade Size (Sh.) (90 D): 1,440
Institutional Trades
Total Inst.Trades: 440
Avg Inst. Trade: $1.33M
Avg Inst. Trade (30 D): $.55M
Avg Inst. Trade (90 D): $.55M
Avg Inst. Trade Volume: .01M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.54M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 9.72K
       
News
Mar 21, 2025 @ 5:52 PM
Accelerate Diagnostics Submits WAVE System and Gra...
Source: Prnewswire
Jan 28, 2025 @ 8:30 AM
Global Antimicrobial Susceptibility Testing Market...
Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.)
Dec 31, 2024 @ 10:58 AM
Antimicrobial Resistance Diagnostic Markets, Strat...
Source: Researchandmarkets.Com
Oct 25, 2024 @ 8:30 PM
Accelerate Diagnostics Scheduled Call to Review 20...
Source: Prnewswire
Jul 22, 2024 @ 5:49 PM
Antimicrobial Resistance Surveillance Market Size ...
Source: Sns Insider
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-2.15 $-.37 $-2.15
Diluted EPS $-2.15 $-2.15
Revenue $ 11.7M $ 2.82M $ 11.7M
Gross Profit $ 2.7M $ .45M $ 2.7M
Net Income / Loss $ -50.05M $ -9.59M $ -50.05M
Operating Income / Loss $ -35.31M $ -7.93M $ -35.31M
Cost of Revenue $ 8.99M $ 2.37M $ 8.99M
Net Cash Flow $ 2.96M $ -4.59M $ 2.96M
PE Ratio